Recurrent erysipelas: Predisposing factors and costs of prophylaxis
Tóm tắt
After an average follow-up time of three years, recurrent erysipelas was observed in 29% of 143 patients admitted primarily with erysipelas. Nineteen patients (13%) had two or more recurrences during this period. The predisposing factor with the highest recurrence rate was venous insufficiency. Regular prophylaxis with phenoxymethylpenicillin (or erythromycin in penicillin allergics) after the second recurrence may be cost-effective. This antibiotic prophylaxis is only recommended in patients with predisposing factors who have suffered severe attacks.
Tài liệu tham khảo
Bisno, A. L. Streptococcal infections. In: Harrison's principles of medicine, (10th ed.) Mc Graw Hill, New York 1983, pp. 928–935.
Bisno, A. L. Postmastectomy edema and recurrent cellulitis. J. Amer. Med. Assoc. 247 (1982) 3359–3360.
Hable, K. A., Horstmeier, C., Wold, A., Washington, J. A. Group A β-hemolytic streptococcemia. Mayo Clin. Proc. 48 (1973) 336–339.
Ziebart-Schroth, A. Zur Therapie und Prophylaxe des rezidivierenden Erysipels. Med. Klin. 71 (1976) 1197–1199.
Bitnun, S. Prophylactic antibiotics in recurrent erysipelas. Lancet I (1985) 345.
Thind, P. Prophylactic antibiotics in recurrent erysipelas. Lancet I (1985) 986.
Duvanel, T., Merot, Y., Harms, M., Sur, J. H. Prophylactic antibiotics in erysipelas. Lancet I (1985) 1401.
Herrmann, W. P., Galosi, A., Reinhold, M. Rezidivierendes Erysipel. Diagnostik 14 (1981) 79–82.
Jorup-Rönström, C., Britton, S., Gavlevik, A., Gunnarsson, K., Redman, A-C. The course, costs and complications of oral versus intravenous penicillin treatment of erysipelas. Infection 12 (1984) 390–394.